EBV
Cell Block Preparation Preserves Details of Cellular RNA
Published in Cancer Weekly, November 2nd, 1998
J. Huh et al. investigated the feasibility of using a cell block preparation of Epstein-Barr virus (EBV)-infected Burkitt's lymphoma cell line (EB-3) as a positive control for in situ hybridization (ISH) for EBV-encoded RNA (EBER) ("Cell Block Preparation of a Burkitt's Lymphoma Cell Line as a Positive Control for In Situ Hybridization for Epstein-Barr Virus," Acta Cytologica, September-October 1998;42(5):1144-1148).
The researchers processed EB-3 cells into cell block and cytocentrifuge preparations. They performed ISH for EBER...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (1998-11-02)
More Articles from Cancer Weekly
- Suicide Gene Therapy
Nonhuman Primate Study Suggests Intracerebral Suicide Gene Therapy Feasible - Cancer Immunology
Suppression of IL-8 in Certain Cancers Affects Autocrine Growth Factors - Cancer Immunotherapy
CD40/CD40L Interaction Helps Generate Enhanced CTL Activity - Cancer Immunotherapy
IL-2 Mediates Durable Responses in Metastatic Cancer Patients - Cancer Immunotherapy
IL-2 Stimulates Signal Transducers and Activators of Transcription - Bone Marrow Transplantation
Pancytopenia Is Undesired Side Effect of Lymphocyte Infusions - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
